INVA

Innoviva, Inc. Common Stock

$13.84 +$0.03 +0.22%



Shares Bought11
Shares Sold11
Total22
Shares Owned0
Last Price$13.84
Total Return$6.72
Range Today$13.62 - $14.20
52 Week Range$8.67 - $14.55
Open$14.15
Market Cap$1.51B
Volume/Average590.72K/1.05M
P/E Ratio16.47
Dividend/Yield0.00




Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.


Orders

Date Side Shares Price
08-03-2017 15:03:25 buy 1 $12.84
08-03-2017 15:04:32 buy 1 $12.84
08-03-2017 15:05:55 buy 1 $12.83
08-03-2017 15:13:16 buy 1 $12.83
08-03-2017 15:14:06 buy 1 $12.84
08-03-2017 15:15:22 buy 1 $12.83
08-03-2017 15:16:23 buy 1 $12.82
08-03-2017 15:24:15 buy 1 $12.83
08-03-2017 15:29:23 buy 1 $12.85
08-03-2017 15:32:35 buy 1 $12.82
08-03-2017 15:34:18 buy 1 $12.83
08-03-2017 15:35:23 sell 1 $12.85
08-07-2017 14:11:22 sell 1 $12.79
08-07-2017 14:15:18 sell 1 $12.79
08-07-2017 14:31:07 sell 1 $12.78
08-07-2017 14:33:54 sell 1 $12.77
09-06-2017 19:35:23 sell 1 $14.05
09-06-2017 19:37:39 sell 1 $14.02
09-06-2017 19:40:58 sell 1 $14.01
09-06-2017 19:43:43 sell 1 $14.06
09-15-2017 20:53:00 sell 1 $13.87
09-15-2017 20:54:37 sell 1 $13.88